ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Nashville, TN, USA:

Study of VYD2311 for the Prevention of COVID-19 (DECLARATION)

The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...

Not yet enrolling
COVID-19
Drug: VYD2311-SD
Drug: VYD2311-MD

Phase 3

Invivyd

Goodlettsville, Tennessee, United States and 18 other locations

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of spe...

Enrolling
Long COVID
Diagnostic Test: RNA Biomarker Blood Test
MaxWell Clinic, PLC

Brentwood, Tennessee, United States and 1 other location

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Nashville, Tennessee, United States and 66 other locations

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...

Active, not recruiting
COVID-19 (Coronavirus Disease 2019)
Influenza
Biological: Investigational COVID-19 Vaccine
Combination Product: Investigational Influenza and COVID-19 Combination Vaccine

Phase 1, Phase 2

BioNTech
BioNTech

Nashville, Tennessee, United States and 31 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 2, Phase 3

BioNTech
BioNTech

Nashville, Tennessee, United States and 122 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Enrolling
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Hendersonville, Tennessee, United States of America and 149 other locations

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
Other: Placebo

Phase 2, Phase 3

Novavax
Novavax

Nashville, Tennessee, United States and 94 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

Nashville, Tennessee, United States and 434 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

Nashville, Tennessee, United States and 499 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems